These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30397059)

  • 41. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
    Jin J; Zhou H; Cui ZC; Wang L; Luo PF; Ji SZ; Hu XY; Ma B; Wang GY; Zhu SH; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):225-232. PubMed ID: 29690741
    [No Abstract]   [Full Text] [Related]  

  • 42. Tigecycline for Acinetobacter baumannii infection: other considerations.
    Curcio D; Fernández F
    Clin Infect Dis; 2008 Jun; 46(11):1797-8; author reply 1798-9. PubMed ID: 18462123
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
    Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
    Xia J; Zhang D; Xu Y; Gong M; Zhou Y; Fang X
    Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
    Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
    Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic options for Acinetobacter baumannii infections.
    Vila J; Pachón J
    Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility to tigecycline of Acinetobacter baumannii strains isolated from intensive care unit patients.
    Talaga K; Krzyściak P; Bulanda M
    Anaesthesiol Intensive Ther; 2016; 48(3):166-70. PubMed ID: 27013253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model.
    Kang AD; Smith KP; Berg AH; Truelson KA; Eliopoulos GM; McCoy C; Kirby JE
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Voulgaris GL; Papanikolaou G; Legakis N;
    Int J Antimicrob Agents; 2018 Aug; 52(2):269-271. PubMed ID: 29559273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
    Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
    BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EVALUATION OF IN VITRO TIGECYCLINE ACTIVITY AGAINST MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII CLINICAL ISOLATES FROM POLAND.
    Paluchowska P; Nowak P; Skalkowska M; Bjdak A
    Acta Pol Pharm; 2017 May; 74(3):793-800. PubMed ID: 29513948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae.
    Yuhan Y; Ziyun Y; Yongbo Z; Fuqiang L; Qinghua Z
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):165-71. PubMed ID: 27192584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
    Pei G; Mao Y; Sun Y
    Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
    Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
    Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
    Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure.
    Liou BH; Lee YT; Kuo SC; Liu PY; Fung CP
    Antimicrob Agents Chemother; 2015; 59(6):3637-40. PubMed ID: 25824230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A combination regimen of meropenem, cefoperazone-sulbactam and minocycline for extensive burns with pan-drug resistant Acinetobacter baumannii infection.
    Ning F; Shen Y; Chen X; Zhao X; Wang C; Rong Y; Du W; Wen C; Zhang G
    Chin Med J (Engl); 2014; 127(6):1177-9. PubMed ID: 24622455
    [No Abstract]   [Full Text] [Related]  

  • 60. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.
    Peleg AY; Potoski BA; Rea R; Adams J; Sethi J; Capitano B; Husain S; Kwak EJ; Bhat SV; Paterson DL
    J Antimicrob Chemother; 2007 Jan; 59(1):128-31. PubMed ID: 17082201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.